Compile Data Set for Download or QSAR
Report error Found 262 Enz. Inhib. hit(s) with Target = 'Short transient receptor potential channel 5'
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50519473(CHEMBL4546097)
Affinity DataIC50: 0.520nMAssay Description:Inhibition of human TRPC5 expressed in human T-REx-293 cells assessed as reduction in lanthanum-activated TRPC5-mediated currents by whole-cell patch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246466(US9447114, 27)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246446(US9447114, 2)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246445(US9447114, 1)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50519465(CHEMBL4466522)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in englerin A-induced calcium entry incubated for 30 mins by Fluo-4AM dye b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246463(US9447114, 24)
Affinity DataIC50: 1.84nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50: 1.91nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647392(CHEMBL5598527)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647396(CHEMBL5597024)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698777(US20240317755, Compound L002)
Affinity DataIC50: 6.52nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698778(US20240317755, Compound L007)
Affinity DataIC50: 7.37nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50601267(ENGLERIN A | CHEBI:72441 | Englerin A)
Affinity DataEC50:  7.60nMAssay Description:Agonist activity at human TRPC5 stably expressed in HEK293 cells assessed as increase in calcium flux by Fura-2AM dye based fluorescence plate reader...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647396(CHEMBL5597024)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647393(CHEMBL4752870)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647397(CHEMBL5597219)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532611(CHEMBL4562137)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532611(CHEMBL4562137)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 9nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 9nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647402(CHEMBL5596183)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647385(CHEMBL5597910)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50519473(CHEMBL4546097)
Affinity DataIC50: 9.30nMAssay Description:Inhibition of human TRPC5 expressed in human T-REx-293 cells assessed as reduction in calcium influx by Fluo-4AM dye based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698776(US20240317755, Compound L001)
Affinity DataIC50: 10.8nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698782(US20240317755, Compound L015)
Affinity DataIC50: 11.5nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50599832(CHEMBL5201831)
Affinity DataIC50: 14nMAssay Description:Inhibition of human TRPC5 channel expressed in HEK293 cells assessed as inhibition of EA-evoked channel current measured at +80 mV by whole-cell volt...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698780(US20240317755, Compound L013)
Affinity DataIC50: 14.6nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246464(US9447114, 25)
Affinity DataIC50: 15.7nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698781(US20240317755, Compound L014)
Affinity DataIC50: 18.2nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647389(CHEMBL5590573)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246453(US9447114, 13)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 23nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 23nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50647401(CHEMBL5596485)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM698783(US20240317755, Compound L019)
Affinity DataIC50: 24nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246449(US9447114, 5)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 27nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetShort transient receptor potential channel 5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM246450(US9447114, 6)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/28/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 262 total ) | Next | Last >>
Jump to: